Article

Landscape of molecular events regulating multiple myeloma cell responses to natural killer cells

2021-01-01

Abstract excerpt

Immunotherapy has remarkably changed the treatment paradigm in hematologic malignancies and natural killer (NK) cell therapy represents an attractive option. However, there have been, to our knowledge, no genome-wide CRISPR-based screens to identify candidate markers of response to NK cells in multiple myeloma (MM), which remains incurable. Furthermore, the molecular markers determining cancer cell resistance to N...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ce7698ce-032a-5927-82b0-ef314748230a
DOI: 10.21954/ou.ro.0001314f

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Landscape of molecular events regulating multiple myeloma cell responses to natural killer cellsDOI 10.21954/ou.ro.0001314fRead

Single-cell transcriptomic analysis of NK cell dynamics in myeloma patients reveal persistent reduction of cytotoxic NK cells from diagnosis to relapseSemantic proximity Read

Single-cell profiling of human bone marrow reveals multiple myeloma progression is accompanied by an increase in CD56 <sup>bright</sup> bone marrow resident NK cellsSemantic proximity Read

Integrative Genomic, Single-Cell, and Functional Profiling of the CD48–CD244 Axis and NK-Cell Dysfunction in Multiple MyelomaSemantic proximity Read

Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myelomaSemantic proximity Read

Single‐cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myelomaSemantic proximity Read

Inflamed Natural Killer cells with adhesion defects are associated with a poor prognosis in Multiple MyelomaSemantic proximity Read

Functional transcriptomic landscape informs novel therapeutic strategies in multiple myelomaSemantic proximity Read

Inflammatory microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myelomaSemantic proximity Read

Applying CRISPR-based genetic screens to identify drivers of tumor-cell sensitivity towards NK-cell attackSemantic proximity Read

Acquired resistance to bispecific antibodies by genetic or epigenetic inactivation of the target in multiple myelomaSemantic proximity Read

Identification of WNK1 as a therapeutic target to suppress IgH/MYC expression in multiple myelomaSemantic proximity Read

PIM2 Kinase Regulates TIGIT Expression and Function in NK Cells from Multiple Myeloma PatientsSemantic proximity Read